Dr Daniel Cooper PhD (Neuro), BSc (Hons) (Biochem.)

Dr Daniel Cooper PhD (Neuro), BSc (Hons) (Biochem.)

Neuropsychotherapist and Co-Programme Lead

Dan is Bayberry’s Neuropsychotherapist and co-programme lead. He holds a first class degree in Biochemistry, a PhD in Neuroscience and a diploma in psychotherapy. He is a published researcher and presented his work at the global neuroscience conference ‘Neuroscience 2019’ in Chicago, having also presented in Dublin in 2018. He has published in prestigious journals, including the Journal of Neuropharmacology and is recognised as a Certified Member of the International Association of Applied Neuroscience.

Neuropsychotherapy combines the scientific understanding of the neurological mechanisms of the brain, with behavioural science and psychotherapeutic techniques – in practice, this is the use of psycho-education to allow clients to understand and work with their own processes.

He has a special interest in environmental factors relating to mental and emotional wellbeing and has studied the neurological effects of enriched environments on long term wellbeing. He is an engaging and personable clinician with a wealth of information that is delivered in a contextual and relevant style, providing the framework to support clients in their understanding of the neural mechanisms of the mind and help to engender a sense of self determination and personal volition.


The Kinase Function of MSK1 Regulates BDNF Signaling to CREB and Basal Synaptic Transmission, But Is Not Required for Hippocampal Long-Term Potentiation or Spatial Memory (2017)

Experience Recruits MSK1 to Expand the Dynamic Range of Synapses and Enhance Cognition (2020)

The influence of sensory experience on the glutamatergic synapse (2021)